Evidence map›Paper›PMID 34177764›Full record

ReviewFrontiers in neurology2021

Paroxysmal Movement Disorders.

Susan Harvey, Mary D King, Kathleen M Gorman

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Update on Genetic Chorea.European journal of neurology · 2025
    Review
  5. Review
  6. Rare Movement Disorders-An Approach for Clinicians.International journal of molecular sciences · 2025
    Review
  7. Review
  8. Evaluating the Performance ofCombinatorial chemistry & high throughput screening · 2025
    Article
  9. Review
  10. Variants inFrontiers in pediatrics · 2024
    Review
  11. Scoping Review on ADCY5-Related Movement Disorders.Movement disorders clinical practice · 2023
    Article
  12. Genetic Links to Episodic Movement Disorders: Current Insights.The application of clinical genetics · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Susan HarveyDepartment of Paediatric Neurology and Clinical Neurophysiology, Children's Health Ireland at Temple Street, Dublin, Ireland.
Mary D KingDepartment of Paediatric Neurology and Clinical Neurophysiology, Children's Health Ireland at Temple Street, Dublin, Ireland.
Kathleen M GormanDepartment of Paediatric Neurology and Clinical Neurophysiology, Children's Health Ireland at Temple Street, Dublin, Ireland.
University College Dublin · IEChildren's Health Ireland at Crumlin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paroxysmal movement disorders (PxMDs) are a clinical and genetically heterogeneous group of movement disorders characterized by episodic involuntary movements (dystonia, dyskinesia, chorea and/or ataxia). Historically, PxMDs were classified clinically (triggers and characteristics of the movements) and this directed single-gene testing. With the advent of next-generation sequencing (NGS), how we classify and investigate PxMDs has been transformed. Next-generation sequencing has enabled new gene discovery (

Indexed as

episodic ataxiageneticsnext-generation sequencingparoxysmal dyskinesiaparoxysmal movement disorders

Identifiers

PMID34177764
PMCPMC8232056
OpenAlexW3172544656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.